Why IMU is a multi multi bagger, page-53

Kitty... Yes Very Soon IMHO , didn’t you see the clinicaltrials.gov website has just been updated with the PD1Vax trial noted to start this month, as posted by QiQi. Therefore approval a formality.

*Pilbaraboy ... hard to believe that stock just catapulted to a A$ 340 milliOn market cap on the back of that announcement “engaging with FDA” . no data, no approval, no deal, just a pathway to proceed. And twice our MC with Imu having a far more advanced multi product pipeline with two platform technologies ... seriously how poor at judging value is the “marketplace” .

On that basis outstanding ph2 HerVax Data will raise some eyebrows very shortly. The probability of a Big Pharma license deal this year is huge. Yet the market currently prices in failure! Go figure.

CF33 Ind approval still to come. 20- 30c not out of the question if the market reads between the lines, and the actual lines soon to be printed, and takes some steroids that seem to be going on elsewhere